Skip To Main Content
Megan Noe on Muck Rack

Megan Noe

  • Video Content Producer, MU Health Care
Columbia
As seen in: JAMA (The Journal of the American Medical Association), Medscape, Healio Dermatology, Healio Cardiac/Vascular Intervention, WQAD-TV (Moline, IL), Dialnet - Universidad de La Rioja, KCRG-TV (Cedar Rapids, IA), KAMR-TV (Amarillo, TX), Journal of The American Academy of Dermatology (JAAD), JAAD International
Comms Director for the Missouri Chamber, formerly @muhealth and @WQAD. #MizzouMade. Quad City Native. Taco aficionado.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Megan

Contact Megan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis

|
By Alexandra Charrow, David Stein, John S. Barbieri, Megan Noe
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis Autores: Bruna Galvao de Oliveira Wafae, Alexandra P. Charrow, David Stein, John S. Barbieri, Megan H. Noe Localización: JAMA Dermatology, ISSN 2168-6068, Vol. 161, Nº. 11, 2025, págs.
Open in Who Shared Issue with article?

Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis

|
By Alexandra Charrow, David Stein, John S. Barbieri, Megan Noe
| buff.ly
Figure 1. Flowchart of Cohort Selection HS indicates hidradenitis suppurativa; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Figure 2.
Open in Who Shared Issue with article?

The Best Psoriasis Medications Emerge

|
By Andrew Blauvelt, Megan Noe
| JAMA (The Journal of the American Medical Association) Verified
Abstract Clinical Question What are the most effective systemic medications to treat plaque psoriasis? Bottom Line The most effective drugs for psoriasis were infliximab, bimekizumab, ixekizumab, and risankizumab, and the clinical effectiveness was similar when these 4 drugs were compared against one another. No statistically significant differences in serious adverse events were identified in any of the drugs compared with placebo.
Open in Who Shared Issue with article?
See all 332 articles